Early diagnosis of pancreatic cancer by urine test announced by Hirotsu Bio
November 16, 2021, Tokyo, Japan - Japanese biological venture Hirotsu Bio Science president Takaaki Hirotsu announces as they developed a screening system to detect early-stage pancreatic cancer patients using their N-Nose system in Tokyo on Tuesday, November 16, 2021. N-Nose system uses odor sensor of nematodes for cancer patients' urine, a specific nematode (C.elegans) shows attractive or repulsive responses for the urine of cancer and healthy persons. (Photo by Yoshio Tsunoda/AFLO)